Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03384914
Title Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Emory - Winship Cancer Institute Atlanta Georgia 30322 United States Details
Indiana University - Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Ohio State University - Arthur G James Cancer Hospital & Richard J Solove Research Institute Columbus Ohio 43210 United States Details
University of Washington, Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field